GAd-209-FSP low dose, MVA-209-FSP low dose, GAd-209-FSP high dose, MVA-209-FSP high dose — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-10-30 in 3mo
ESTIMATED |
READOUT
Nous-209 Genetic Vaccine for the Treatment of Microsatellite Unstable Solid Tumo
Phase 1/2 · Solid Tumor, Adult |
Nouscom SRL | GAd-209-FSP low dose, MVA-209-FSP low do |
ClinicalTrials.gov ↗
✓ Source-checked 2026-08-06
Sponsor-projected date — can change
|